Your browser doesn't support javascript.
loading
Using Ribonucleoprotein-based CRISPR/Cas9 to Edit Single Nucleotide on Human Induced Pluripotent Stem Cells to Model Type 3 Long QT Syndrome (SCN5A±).
Ge, Ning; Liu, Min; Li, Rui; Allen, Nicholas M; Galvin, Joseph; Shen, Sanbing; O'Brien, Timothy; Prendiville, Terence W.
Affiliation
  • Ge N; Regenerative Medicine Institute, School of Medicine, College of Medicine, Nursing and Health Science, University of Galway, Galway, Ireland.
  • Liu M; Department of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Li R; Department of Physiology, College of Life Science, Hebei Normal University, Shijiazhuang, China.
  • Allen NM; Lambe Institute for Translational Research, University of Galway, Galway, Ireland.
  • Galvin J; Regenerative Medicine Institute, School of Medicine, College of Medicine, Nursing and Health Science, University of Galway, Galway, Ireland.
  • Shen S; Department of Paediatrics, University of Galway, Galway, Ireland.
  • O'Brien T; Mater Misericordiae University Hospital, Eccles St., Dublin 7, Ireland.
  • Prendiville TW; Regenerative Medicine Institute, School of Medicine, College of Medicine, Nursing and Health Science, University of Galway, Galway, Ireland.
Stem Cell Rev Rep ; 19(8): 2774-2789, 2023 11.
Article in En | MEDLINE | ID: mdl-37653182

Full text: 1 Database: MEDLINE Main subject: Long QT Syndrome / Induced Pluripotent Stem Cells Type of study: Guideline / Prognostic_studies Limits: Humans Language: En Journal: Stem Cell Rev Rep Year: 2023 Type: Article Affiliation country: Ireland

Full text: 1 Database: MEDLINE Main subject: Long QT Syndrome / Induced Pluripotent Stem Cells Type of study: Guideline / Prognostic_studies Limits: Humans Language: En Journal: Stem Cell Rev Rep Year: 2023 Type: Article Affiliation country: Ireland